5 Essential Elements For "3
Other scientific trials in clients with non-Hodgkin's lymphoma [24] and clients with Highly developed malignancy [fourteen] have demonstrated also that zosuquidar did not substantially influence the pharmacokinetics of doxorubicin and had average outcomes to the pharmacokinetics of vincristine. These medical trials accredited that zosuquidar could